Oxime bond-linked daunorubicin-GnRH-III bioconjugates exert antitumor activity in castration-resistant prostate cancer cells via the type I GnRH receptor.
about
P2860
Oxime bond-linked daunorubicin-GnRH-III bioconjugates exert antitumor activity in castration-resistant prostate cancer cells via the type I GnRH receptor.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Oxime bond-linked daunorubicin ...... via the type I GnRH receptor.
@en
Oxime bond-linked daunorubicin ...... via the type I GnRH receptor.
@nl
type
label
Oxime bond-linked daunorubicin ...... via the type I GnRH receptor.
@en
Oxime bond-linked daunorubicin ...... via the type I GnRH receptor.
@nl
prefLabel
Oxime bond-linked daunorubicin ...... via the type I GnRH receptor.
@en
Oxime bond-linked daunorubicin ...... via the type I GnRH receptor.
@nl
P50
P356
P1476
Oxime bond-linked daunorubicin ...... s via the type I GnRH receptor
@en
P2093
Marilena Manea
Patrizia Limonta
P304
P356
10.3892/IJO.2014.2730
P577
2014-10-24T00:00:00Z